New immunotherapy strategy targets macrophage receptors to enhance melanoma treatment
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
Medscape1d
New Bifunctional Drug Shows Sustained Effect in Alopecia Areata
In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...
Business Wire1d
Celltrion's Infliximab, the First Monoclonal Antibody Biosimilar, Is Now Remdantry™ in Canada
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
Hoodline3d
Vanderbilt's High-Tech Quest for the Holy Grail of Antibody Therapy, $30M ARPA-H Grant Catapults AI Revolution in Disease Treatment
VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...
New Antibody Therapy Shows Promise Against All COVID Variants – And the Future Ones Too
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...